Where tomorrow’s medicines begin and Africa’s health future is forged
South Africa’s pharmaceutical landscape is marked by ambition, urgency and stark inequities. The continent carries 25 percent of the global disease burden but produces only a fraction of the medicines it consumes. Bridging this gap requires more than scientific talent; it demands infrastructure, accreditation and an ecosystem that can move a molecule from idea to impact. At the North-West University (NWU), the Preclinical Drug Development Platform (PCDDP) is positioning itself as precisely that bridge.